Shares of Compass Therapeutics (NASDAQ:CMPX) were up 8% in afternoon trading Monday after Guggenheim initiated coverage of ...
Shares of Compass (NYSE: COMP), the nation's largest real estate brokerage, were climbing this week after the company ...
As previously reported, Guggenheim analyst Michael Schmidt initiated coverage of Compass Therapeutics (CMPX) with a Buy rating and $12 price ...
Compass CEO Robert Reffkin has made exclusive listings central to the company’s business strategy, but CCP serves as a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback